Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Go back to Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
(NASDAQ: VRCA) Delayed: 5.30 -0.06 (1.12%)
Previous Close $5.36    52 Week High
Open $5.28    52 Week Low
Day High $5.53    P/E N/A 
Day Low $5.25    EPS
Volume 12,198